Review of microbial infections and the immune response to cardiac antigens

Journal of Infectious Diseases

Volumn 181, Issue 6 SUPPL. 3, 2000, Pages

  Penninger, Josef M ^a   Bachmaier, Kurt ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEART ANTIGEN;

CARDIOMYOPATHY; CONFERENCE PAPER; CYTOPATHOGENIC EFFECT; EPITOPE MAPPING; HEART DISEASE; IMMUNE RESPONSE; IMMUNE SYSTEM; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TARGET ORGAN;

EID: 0034086561     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315613     Document Type: Conference Paper

References (41)

1. 1. Rose NR. Myocarditis: from infection to autoimmunity. The Immunologist 1996; 4:67-75.
2. 2. Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980; 101:425-84.
3. 3. Fenoglio JJ Jr, Ursell PC, Kellogg CF, Drusin RE, Weiss MB. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med 1983; 308:12-8.
4. 4. Keating MT, Sanguinetti MC. Molecular genetic insights into cardiovascular disease. Science 1996; 272:681-5.
5. 5. James TN. Myocarditis and cardiomyopathy [editorial]. N Engl J Med 1983; 308:39-41.
6. 6. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985; 312:885-90.
7. 7. Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994; 74:182-8.
8. 8. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-6.
9. 9. Ossewaarde JM, Feskens EJM, DeVries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacler pylori and cytomegalovirus are not. Epidemiol Infect 1998; 120:93-9.
10. 10. Grayston JT, Mordhorst CH, Wang SP. Childhood myocarditis associated with Chlamydia trachomatis infection. JAMA 1981; 246:2823-7.
11. 11. Odeh M, Oliven A, Rauchfleisch S, Bassan H. Dilated cardiomyopathy associated with Chlamydia trachomatis infection. J Intern Med 1991; 229: 289-91.
12. 12. Munoz B, West S. Trachoma: the forgotten cause of blindness. Epidemiol Rev 1997; 19:205-17.
13. 13. Stokes T. Screening for chlamydia in general practice: a literature review and summary of the evidence. J Public Health Med 1997; 19:222-32.
14. 14. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri GG, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139:3630-6.
15. 15. Neu N, Craig SW Rose NR, et al. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol 1987; 69:566-74.
16. 16. Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today 1988;9: 117-20.
17. 17. Liu P, Aitken K, Kong YY, et al. Essential role for the tyrosine kinase p561ck in Coxsackievirus B3-mediated heart disease. Nat Med 2000; 6:429-34.
18. 18. Pummerer C, Berger P, Fruhwirth M, Ofner C, Neu N. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. Lab Invest 1991; 65: 538-47.
19. 19. Pummerer CL, Grassl G, Sailer M, Bachmaier KV, Penninger JM, Neu N. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Lab Invest 1996; 74:845-52.
20. 20. Bachmaier K, Pummerer C, Kozieradzki I, et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation 1997; 95:655-61.
21. 21. Bachmaier K, Pummerer C, Shahinian A, et al. Induction of autoimmunity in the absence of CD28 costimulation. J Immunol 1996; 157:1752-7.
22. 22. Penninger JM, Neu N, Timms E, et al. Induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J Exp Med 1993; 178:1837-42.
23. 23. Smith SC, Allen PM. Expression of myosin class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA 1992; 89:9131-5.
24. 24. Penninger JM, Neu N, Bachmaier K. A genetic map of autoimmune heart disease. The Immunologist 1996; 4:131-41.
25. 25. Bachmaier K, Pummerer C, Kozieradzki I, et al. Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease [see comments]. Circulation 1997; 95:655-61.
26. 26. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure [see comments]. Circulation 1996; 93:1087-94.
27. 27. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy [see comments]. Lancet 1996; 347:1151-5.
28. 28. Bachmaier K, Neu N, Pummerer C, et al. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997; 96: 585-91.
29. 29. Bachmaier K, Neu N, Yeung RSM, Mak TW, Liu P, Penninger JM. Generation of humanized mice susceptible to peptide-induced inflammatory heart disease. Circulation 1999; 99:1885-91.
30. 30. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15:321-31.
31. 31. Pummerer CL, Luze K, Grassl G, et al. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Invest 1996; 97:2057-62.
32. 32. Donermeyer DL, Beisel KW, Allen PM, Smith SC. Myocarditis-inducing epitope of myosin binds constitutiveiy and stably to I-A(k) on antigen-presenting cells in the heart. J Exp Med 1995; 182:1291-300.
33. 33. Wegmann KW, Zhao W, Griffin AC, Hickey WE Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. J Immunol 1994; 153: 892-900.
34. 34. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999; 283:1335-9.
35. 35. Zabriskie JB, Friedman JE. The role of heart binding antibodies in rheumatic fever. Adv Exp Med Biol 1983; 161:457-70.
36. 36. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819-20; [erratum] 1987; 51:878.
37. 37. Janeway CA. A tale of two T cells. Immunity 1998; 8:391-4.
38. 38. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4:781-5.
39. 39. Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-9.
40. 40. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 1998; 160:870-6.
41. 41. Messina JP, Gilkeson GS, Pisetsky DS. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 1991; 147:1759-64.